GlassScriptPhysician profile
Benjamin Francis Klug
NPI 1265793137
$8,307.43
in general payments reported to CMS, 2019-2025
15 companies · $224 in 2025
The $224 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $193 · 2020: $7,571 · 2021: $125 · 2022: $84.77 · 2023: $87.62 · 2024: $22.76 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $235 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $235.20 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,570.62 | 2020 | |
| Astellas Pharma US INC | $153.86 | 2023-2025 | Veozah |
| Conmed Corporation | $125.00 | 2021 | |
| Abbvie INC. | $95.98 | 2019-2022 | |
| Daiichi Sankyo INC. | $72.38 | 2019-2022 | |
| Organon LLC | $55.45 | 2022-2025 | Nexplanon |
| Karl Storz Endoscopy-America | $43.77 | 2019 | |
| Boston Scientific Corporation | $32.42 | 2019-2023 | Advantage System |
| Octapharma USA, INC. | $30.82 | 2025 | Fibryga |
| Novo Nordisk INC | $29.80 | 2023 | Wegovy |
| Biogen, INC. | $26.62 | 2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $22.76 | 2024 | |
| Olympus America INC. | $17.56 | 2023 | Olympus |
| Pacira Pharmaceuticals Incorporated | $17.12 | 2019 | |
| Merck Sharp & Dohme LLC | $13.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Klug listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.